Koichi Akashi

41.5k total citations · 8 hit papers
680 papers, 29.8k citations indexed

About

Koichi Akashi is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Koichi Akashi has authored 680 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 250 papers in Hematology, 214 papers in Immunology and 171 papers in Oncology. Recurrent topics in Koichi Akashi's work include Acute Myeloid Leukemia Research (110 papers), Hematopoietic Stem Cell Transplantation (105 papers) and Immune Cell Function and Interaction (76 papers). Koichi Akashi is often cited by papers focused on Acute Myeloid Leukemia Research (110 papers), Hematopoietic Stem Cell Transplantation (105 papers) and Immune Cell Function and Interaction (76 papers). Koichi Akashi collaborates with scholars based in Japan, United States and United Kingdom. Koichi Akashi's co-authors include Irving L. Weissman, Toshihiro Miyamoto, Hiromi Iwasaki, David Traver, Motonari Kondo, Hirokazu Shigematsu, Daniel G. Tenen, Mine Harada, Shin-ichi Mizuno and Takanori Teshima and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Koichi Akashi

636 papers receiving 29.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

2000 1.9k citations Koichi Akashi, David Traver et al. profile →
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow

1997 1.6k citations Irving L. Weissman, Koichi Akashi et al. profile →
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

2005 733 citations Shuro Yoshida, Toshihiro Miyamoto et al. Blood profile →
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region

2007 717 citations Shuro Yoshida, Noriyuki Saito et al. profile →
The aging of hematopoietic stem cells

1996 642 citations Koichi Akashi, Irving L. Weissman et al. profile →
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors

2004 513 citations Hirokazu Shigematsu, Koichi Akashi et al. profile →
Mouse Development and Cell Proliferation in the Absence of D-Cyclins

2004 509 citations Hirokazu Shigematsu, Koichi Akashi et al. profile →
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

2015 367 citations Koji Nagafuji, Koichi Akashi et al. Blood profile →

Peers

Countries citing papers authored by Koichi Akashi

Since Specialization

Citations

This map shows the geographic impact of Koichi Akashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Akashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Akashi more than expected).

Fields of papers citing papers by Koichi Akashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Akashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Akashi. The network helps show where Koichi Akashi may publish in the future.

Co-authorship network of co-authors of Koichi Akashi

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Akashi. A scholar is included among the top collaborators of Koichi Akashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Akashi. Koichi Akashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism 2024 ·Blood Advances ·(unknown), Yoshikane Kikushige, (unknown), Shunsuke Yamamoto, (unknown), (unknown), Toshihiro Miyamoto, (unknown), Andy Christoforou, Yuya Kunisaki, Mitsuhiro Fukata, Koji Kato, Takumi Ito, Hiroshi Handa, Koichi Akashi	2
2	Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells 2024 ·PubMed ·(unknown), Yuichiro Semba, Kensuke Sasaki, Kiyoko Setoguchi, (unknown), Takuji Yamauchi, (unknown), Shigeki Hirabayashi, (unknown), Jumpei Nogami, Shai Izraeli, Koichi Akashi, Takahiro Maeda	5
3	Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia 2023 ·In Vivo ·Mayako Uchida, (unknown), (unknown), (unknown), (unknown), Hideki Ochiai, (unknown), Takehiro Kawashiri, Koji Kato, Nobuaki Egashira, Koichi Akashi, Ichiro Ieiri	0
4	A Case of Japanese Spotted Fever Misdiagnosed as COVID-19 on Admission 2023 ·Kansenshogaku zasshi ·(unknown), (unknown), (unknown), Hiroshi Uchida, Tetsuya Kikuchi, (unknown), (unknown), Masao Tanaka, (unknown), Koichi Akashi	0
5	Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication 2022 ·Open Forum Infectious Diseases ·Naoki Tani, Hideyuki Ikematsu, (unknown), (unknown), (unknown), (unknown), Yasuo Kurata, (unknown), (unknown), (unknown), (unknown), Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong	11
6	Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents 2022 ·Influenza and Other Respiratory Viruses ·Yong Chong, (unknown), Naoki Tani, Akiko Yonekawa, Hideyuki Ikematsu, Nobuyuki Shimono, Yosuke Tanaka, Koichi Akashi	10
7	Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study 2022 ·Modern Rheumatology ·(unknown), Yasutaka Kimoto, Takuya Sawabe, (unknown), (unknown), (unknown), (unknown), (unknown), Masahiro Ayano, Hiroki Mitoma, Nobuyuki Ono, Yojiro Arinobu, Hiroaki Niiro, Taeko Hotta, (unknown), Koichi Akashi, Shiro Ohshima, Tsutomu Takeuchi, Takahiko Horiuchi	9
8	Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning 2022 ·Takeshi Sugio, Koji Kato, Shuro Yoshida, Noriyuki Saito, Ichiro Kawano, Hideho Henzan, Toshihiro Miyamoto, Koichi Akashi, Tetsuya Eto	0
9	Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2- rearranged Ph-like ALL 2021 ·Blood ·Kensuke Sasaki, Takuji Yamauchi, Yuichiro Semba, Jumpei Nogami, (unknown), (unknown), (unknown), Koshi Akahane, Takeshi Inukai, Els Verhoeyen, Koichi Akashi, Takahiro Maeda	13
10	Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML) 2020 ·Blood ·Yasuyoshi Morita, Takayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, Naoko Hosono, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, (unknown), (unknown), Yasushi Miyazaki, Masahiro Kizaki, Koichi Akashi	0
11	Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma 2019 ·Molecular Cancer Therapeutics ·Tatsushi Kodama, (unknown), (unknown), Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi	62
12	Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease 2017 ·European Journal of Rheumatology ·Yojiro Arinobu, Koichi Akashi, Koh‐Hei Sonoda, Tatsuro Ishibashi, (unknown), (unknown), Takahiko Horiuchi, Hiroshi Tsukamoto, Hiroaki Niiro, (unknown), Hiroki Mitoma, Yasutaka Kimoto, Masahiro Ayano, (unknown), Yasushi Inoue, Atsunobu Takeda, Mitsuteru Akahoshi	10
13	C/EBPα is required for development of dendritic cell progenitors 2013 ·Blood ·Robert S. Welner, Deepak Bararia, Giovanni Amabile, Akos Czibere, Touati Benoukraf, Christian Bach, K. D. Senali Abayratna Wansa, Min Ye, Hong Zhang, Tadafumi Iino, Christopher J. Hetherington, Koichi Akashi, Daniel G. Tenen	30
14	Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins 2012 ·Blood ·Yoshihiro Eriguchi, Shuichiro Takashima, (unknown), Sonoko Shimoji, Kiminori Nakamura, Hidetaka Uryu, Shinji Shimoda, Hiromi Iwasaki, Nobuyuki Shimono, Tokiyoshi Ayabe, Koichi Akashi, Takanori Teshima	230
15	FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activation 2009 ·Blood ·Goichi Yoshimoto, Toshihiro Miyamoto, Siamak Jabbarzadeh‐Tabrizi, Tadafumi Iino, Jennifer L. Rocnik, Yoshikane Kikushige, Yasuo Mori, Takahiro Shima, Hiromi Iwasaki, Katsuto Takenaka, Koji Nagafuji, Shin-ichi Mizuno, Hiroaki Niiro, Gary Gilliland, Koichi Akashi	200
16	Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF 2007 ·Science ·Takahiro Maeda, Taha Merghoub, Robin M. Hobbs, Dong Lin, Manami Maeda, Johannes L. Zakrzewski, Marcel R.M. van den Brink, Arthur Zelent, Hirokazu Shigematsu, Koichi Akashi, Julie Teruya‐Feldstein, Giorgio Cattoretti, Pier Paolo Pandolfi	174
17	Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells 2005 ·Science ·Joseph T. Opferman, Hiromi Iwasaki, Christy C. Ong, Heikyung Suh, Shin-ichi Mizuno, Koichi Akashi, Stanley J. Korsmeyer	446
18	Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis 2002 ·Blood ·Koichi Akashi, Xi He, Jie Chen, Hiromi Iwasaki, Chao Niu, Brooke M. Steenhard, Jiwang Zhang, Jeff Haug, Linheng Li	293
19	Differential regulation of the human and murine CD34 genes in hematopoietic stem cells 2002 ·Proceedings of the National Academy of Sciences ·Yutaka Okuno, Hiromi Iwasaki, Claudia S. Huettner, Hanna S. Radomska, (unknown), Daniel G. Tenen, Koichi Akashi	62
20	Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S 2002 ·Journal of Clinical Investigation ·Thanyaphong Na Nakorn, David Traver, Irving L. Weissman, Koichi Akashi	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact